Wild Ride for Stocks, Trump's New Choices, Suspect in Killing of UnitedHealth CEO Pleads "Not Guilty" 12/23/24

Squawk on the Street

CNBC

News, Investing, Business

4.1 • 567 Ratings

🗓️ 23 December 2024

⏱️ 42 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Sara Eisen and Scott Wapner led off the show with broader market's wild ride. The S&P 500 coming off its best day since early November and its worst week since election week. Jefferies Chief Market Strategist David Zervos offered his 2025 market outlook. In the Washington spotlight: President-elect Trump's latest picks to serve in his administration, Elon Musk and Capitol Hill drama. Also in focus: Luigi Mangione -- the man accused of killing UnitedHealthcare CEO Brian Thompson -- enters "not guilty" pleas, chips rally, Qualcomm-Arm court ruling effect, a different kind of ring for Apple, investing in Apollo Global following its addition to the S&P 500. Squawk on the Street Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0	It's Jim Kramer here. You're listening to the opening bell of CBC Squawk on the Street.
0:04.7	Don't miss a minute of the action.
0:07.9	Good Monday morning. Welcome to Squawk on the Street. I'm Sarah Eisen here with Scott Wapner
0:12.1	at Post 9 of the New York Stock Exchange. Carl Jim and David, all have the morning off.
0:16.0	Take a look at futures as we kick off this holiday shortened trading week.
0:19.1	Remember, half day trading tomorrow.
0:21.5	Market closed Wednesday, then open for full day, Thursday and Friday.
0:25.1	We've got a full day today as well.
0:26.4	Futures are a little bit under pressure.
0:27.8	Dow futures down 200.
0:29.5	S&P down 11 and NASDAQ down a little less so.
0:34.0	Our roadmap begins with the markets.
0:35.3	The S&P 500 coming off its best day in a month
0:38.3	and a half, but it's worst week since the election. Also ahead, President Elect Trump reacts
0:43.9	to the post-election attention. Elon Musk has been receiving. Plus, the weight-loss drug wars
0:48.9	Novo Nordus shares rebounding after Friday's 20% slide and Eli Lilly is rising after the FDA approved Zepbound for the treatment of sleep apnea.
0:58.5	We begin with the market after Friday's big rebound rally.
1:02.9	You want to start with the good news or the bad news for the Bulls?
1:05.6	There's bad news?
1:06.5	Well, the bad news is that under the hood, there are signs of decay.
1:11.2	Eight of the 11 S&P sectors are in negative territory for the month of December.
1:15.9	Treasury yields have marched higher, and so is the US dollar.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.